Clinical Trial Update: Comparison of Megestrol and/or Omega-3 Fatty Acid-Enriched Nutritional Supplement in Treating Patients With Cancer-Related Weight Loss and Lack of Appetite [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating megestrol acetate and an omega-3 fatty acid-enriched nutritional supplement for cancer-related weight loss and anorexia has completed e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anorexia
• Cancer Cachexia

Drugs mentioned

• Megace (Megestrol acetate) (Megestrol acetate)
• Omega-3 fatty acid-enriched nutritional supplement (Omega-3 fatty acids)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Anorexia, Cachexia | Phase 3 | Status: COMPLETED